Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
21.14
+0.10 (0.48%)
Nov 13, 2026, 4:00 PM EST - Market closed

Tectonic Therapeutic Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
413390681---
Market Cap Growth
17.08%-42.68%----
Enterprise Value
183123525---
Last Close Price
21.1420.8646.17---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
1.841.554.84---
P/TBV Ratio
1.801.554.84---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.010.02-1.080.170.04
Net Debt / Equity Ratio
-1.01-1.00-0.986.09-0.86-0.98
Net Debt / EBITDA Ratio
2.423.062.450.570.951.77
Net Debt / FCF Ratio
3.334.192.330.601.011.85
Quick Ratio
19.3926.2612.170.704.596.82
Current Ratio
19.7126.6312.650.764.736.95
Return on Equity (ROE)
-35.46%-37.82%-84.79%-276.60%-102.77%-
Return on Assets (ROA)
-23.16%-25.38%-37.71%-64.44%-51.24%-
Return on Capital Employed (ROCE)
-41.60%-33.40%-41.10%2998.50%-83.40%-54.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-21.90%-18.99%-8.51%---
FCF Yield
-16.78%-15.44%-8.70%---
Buyback Yield / Dilution
-9.73%-115.81%-569.30%49.78%--
SEC Filings: 10-K · 10-Q